InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
T+90 hit rate
43%
T+90 mean return
-1.9%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Doherty Catherine T., Deputy Chief Executive. Officer active across 1 company, notably Quest Diagnostics INC. Cumulatively, 22 reports have been recorded. Split: 0 buy · 6 sells. Total volume traded: €3.3m. History available since 7 May 2021. The latest transaction was filed on 5 March 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations22 total
5,370 shares@ US$174.134.2% of flowCommon StockSEC:0001022079-25-000094:0
394 shares@ US$173.740.3% of flowCommon StockSEC:0001022079-25-000091:0
455 shares@ US$171.750.4% of flowCommon StockSEC:0001022079-25-000071:0
535 shares@ US$169.710.4% of flowCommon StockSEC:0001022079-25-000052:0
3,479 shares0Common StockSEC:0001022079-25-000033:0
33,103 shares@ US$103.5715.5% of flowCommon StockSEC:0001022079-24-000206:0
644 shares@ US$126.360.4% of flowCommon StockSEC:0001022079-24-000084:0
9,314 shares@ US$125.025.1% of flowCommon StockSEC:0001022079-24-000064:0
493 shares@ US$125.020.3% of flowCommon StockSEC:0001022079-24-000050:0
4,304 shares0Common StockSEC:0001022079-24-000029:0
9,917 shares@ US$147.866.6% of flowCommon StockSEC:0001022079-23-000069:0
717 shares@ US$140.630.5% of flowCommon StockSEC:0001022079-23-000054:0
392 shares@ US$140.690.2% of flowCommon StockSEC:0001022079-23-000042:0
962 shares@ US$147.860.6% of flowCommon StockSEC:0001022079-23-000030:0
40,765 shares@ US$86.6316.2% of flowCommon StockSEC:0001022079-22-000168:0
13,392 shares@ US$130.090.0084% mcap15.4% of flowCommon StockSEC:0001022079-22-000054:0
2,750 shares@ US$126.260.0016% mcap3.0% of flowCommon StockSEC:0001022079-22-000039:0
1,082 shares@ US$130.090.0006% mcap1.2% of flowCommon StockSEC:0001022079-22-000015:0
37,565 shares@ US$95.7950.017% mcap30.7% of flowCommon StockSEC:0001022079-21-000146:0
37,565 shares@ US$95.7950.017% mcap76.3% of flowCommon StockSEC:0001022079-21-000146
8,536 shares@ US$139.9639.5% of flowCommon StockSEC:0001022079-21-000077
8,536 shares@ US$139.9630.0052% mcap9.5% of flowCommon StockSEC:0001022079-21-000077:0
22 of 22 declarations
About Doherty Catherine T.
Catherine T. Doherty is the Executive Vice President and Group Executive of Clinical Affairs at Quest Diagnostics Inc. She oversees the company's clinical operations, ensuring that services are delivered efficiently and with quality. With significant experience in the diagnostics sector, she plays a key role in optimizing processes and enhancing patient experience. Her leadership is essential for ensuring the company's growth and profitability.
